Search Results - "OLUMI, Aria F"

Personalized medicine for the management of benign prostatic hyperplasia by Bechis, Seth K, Otsetov, Alexander G, Ge, Rongbin, Olumi, Aria F

“…Benign prostatic hyperplasia affects more than 50% of men by age 60 years, and is the cause of millions of dollars in health care expenditure for the treatment…”
Get more information

Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism by FENDT, Sarah-Maria, BELL, Eric L, PATNAIK, Akash, BLOUIN, Marie Jose, CANTLEY, Lewis C, GUARENTE, Leonard, BLENIS, John, POLLAK, Michael N, OLUMI, Aria F, VANDER HEIDEN, Matthew G, STEPHANOPOULOS, Gregory, KEIBLER, Mark A, DAVIDSON, Shawn M, WIRTH, Gregory J, FISKE, Brian, MAYERS, Jared R, SCHWAB, Matthias, BELLINGER, Gary, CSIBI, Alfredo

“…Metformin inhibits cancer cell proliferation, and epidemiology studies suggest an association with increased survival in patients with cancer taking metformin;…”
Get full text

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes by Liu, Deli, Shoag, Jonathan E., Poliak, Daniel, Goueli, Ramy S., Ravikumar, Vaishali, Redmond, David, Vosoughi, Aram, Fontugne, Jacqueline, Pan, Heng, Lee, Daniel, Thomas, Domonique, Salari, Keyan, Wang, Zongwei, Romanel, Alessandro, Te, Alexis, Lee, Richard, Chughtai, Bilal, Olumi, Aria F., Mosquera, Juan Miguel, Demichelis, Francesca, Elemento, Olivier, Rubin, Mark A., Sboner, Andrea, Barbieri, Christopher E.

“…Benign prostatic hyperplasia (BPH), a nonmalignant enlargement of the prostate, is among the most common diseases affecting aging men, but the underlying…”
Get full text

Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy by Wang, Zongwei, Deng, Tuo, Long, Xingbo, Lin, Xueming, Wu, Shulin, Wang, Hongbo, Ge, Rongbin, Zhang, Zhenwei, Wu, Chin-Lee, Taplin, Mary-Ellen, Olumi, Aria F

“…To determine whether SRD5A2 promoter methylation is associated with cancer progression during androgen deprivation therapy (ADT) in CRPC. In a Local CRPC…”
Get full text

Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue by Vandergrift, Lindsey A., Decelle, Emily A., Kurth, Johannes, Wu, Shulin, Fuss, Taylor L., DeFeo, Elita M., Halpern, Elkan F., Taupitz, Matthias, McDougal, W. Scott, Olumi, Aria F., Wu, Chin-Lee, Cheng, Leo L.

“…Prostate cancer alters cellular metabolism through events potentially preceding cancer morphological formation. Magnetic resonance spectroscopy (MRS)-based…”
Get full text

Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer by AIZER, Ayal A, PALY, Jonathan J, OLUMI, Aria F, DROR MICHAELSON, M, D'AMICO, Anthony V, EFSTATHIOU, Jason A, ZIETMAN, Anthony L, NGUYEN, Paul L, BEARD, Clair J, RAO, Sandhya K, KAPLAN, Irving D, NIEMIERKO, Andrzej, HIRSCH, Michelle S, WU, Chin-Lee

“…Multidisciplinary clinics offer a unique approach to the management of patients with cancer. Yet, limited data exist to show that such clinics affect…”
Get full text

Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system by Dong, Fei, Wang, Chaofu, Farris, A Brad, Wu, Shulin, Lee, Hang, Olumi, Aria F, McDougal, W Scott, Young, Robert H, Wu, Chin-Lee

“…The 2005 International Society of Urological Pathology (ISUP) Consensus Conference modified the Gleason grading system for prostate cancer. In the modified…”
Get full text

Metformin inhibits the proliferation of benign prostatic epithelial cells by Wang, Zongwei, Xiao, Xingyuan, Ge, Rongbin, Li, Jijun, Johnson, Cameron W, Rassoulian, Cyrus, Olumi, Aria F

“…Benign prostatic hyperplasia (BPH) is the most common proliferative abnormality of the prostate affecting elderly men throughout the world. Epidemiologic…”
Get full text

MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-jun heterodimers and repressing c-FLIP(L) by WENHUA LI, XIAOPING ZHANG, OLUMI, Aria F

“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent because it induces apoptosis in cancer cells but not in normal…”
Get full text

Management of spermatic cord tumors: a rare urologic malignancy by Rodríguez, Dayron, Olumi, Aria F.

“…Primary spermatic cord tumors are rare yet clinically significant urologic lesions that affect patients of all ages. They are the most common tumors of the…”
Get full text

Primary spermatic cord tumors: Disease characteristics, prognostic factors, and treatment outcomes by Rodríguez, Dayron, M.D., M.P.H, Barrisford, Glen W., M.D, Sanchez, Alejandro, M.D, Preston, Mark A., M.D, Kreydin, Evgeniy I., M.D, Olumi, Aria F., M.D

“…Abstract Introduction Experience with management of spermatic cord tumors (SCTs) is uncommon. We utilized a large population-based cancer registry to…”
Get full text

BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions by Yun, Huiyoung, Bedolla, Roble, Horning, Aaron, Li, Rong, Chiang, Huai-Chin, Huang, Tim-H, Reddick, Robert, Olumi, Aria F, Ghosh, Rita, Kumar, Addanki P

“…COBRA1 (co-factor of BRCA1) is one of the four subunits of the negative elongation factor originally identified as a BRCA1-interacting protein. Here, we…”
Get full text

Sirt1 coordinates with ERα to regulate autophagy and adiposity by Tao, Zhipeng, Shi, Limin, Parke, Jane, Zheng, Louise, Gu, Wei, Dong, X. Charlie, Liu, Dongmin, Wang, Zongwei, Olumi, Aria F., Cheng, Zhiyong

“…Sex difference in adiposity has long been recognized but the mechanism remains incompletely understood. Previous studies suggested that adiposity was regulated…”
Get full text

Correction: Sirt1 coordinates with ERα to regulate autophagy and adiposity by Tao, Zhipeng, Shi, Limin, Parke, Jane, Zheng, Louise, Gu, Wei, Dong, X. Charlie, Liu, Dongmin, Wang, Zongwei, Olumi, Aria F., Cheng, Zhiyong

Get full text

c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells by XIAOPING ZHANG, LIANG ZHANG, HONGMEI YANG, XU HUANG, OTU, Hasan, LIBERMANN, Towia A, DEWOLF, William C, KHOSRAVI-FAR, Roya, OLUMI, Aria F

“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo-2L promotes apoptosis in cancer cells while sparing normal cells. Although many cancers are…”
Get full text

Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations by Li, Lianjie, Zhang, Liang, Zhang, Xiaoping, Yan, Qin, Minamishima, Yoji Andrew, Olumi, Aria F., Mao, Mao, Bartz, Steven, Kaelin, William G.

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer by XIAOPING ZHANG, JIN, Tai-Guang, HONGMEI YANG, DEWOLF, William C, KHOSRAVI-FAR, Roya, OLUMI, Aria F

“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to induce apoptosis in a variety of tumorigenic and transformed cell lines but…”
Get full text

Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome by Wu, Shulin, Lin, Sharron X., Wirth, Gregory J., Lu, Min, Lu, Jian, Subtelny, Alexander O., Wang, Zongwei, Dahl, Douglas M., Olumi, Aria F., Wu, Chin-Lee

“…To assess the impact of focality and location of positive surgical margins (PSM) on long-term outcomes after radical prostatectomy (RP) for prostate cancer…”
Get full text

Smaller prostate gland size and older age predict Gleason score upgrading by Gershman, Boris, M.D, Dahl, Douglas M., M.D, Olumi, Aria F., M.D, Young, Robert H., M.D, McDougal, W. Scott, M.D, Wu, Chin-Lee, M.D., Ph.D

“…Abstract Objectives Gleason score is important for prostate cancer (CaP) risk stratification and prognostication but has a significant rate of upgrading. We…”
Get full text

Clinical features of leiomyosarcoma of the urinary bladder: Analysis of 183 cases by Rodríguez, Dayron, M.D., M.P.H, Preston, Mark A., M.D, Barrisford, Glen W., M.D., M.S, Olumi, Aria F., M.D, Feldman, Adam S., M.D., M.P.H

“…Abstract Introduction Experience with management of urinary bladder leiomyosarcoma (LMS) is rare. Therefore, to better elucidate the disease characteristics of…”
Get full text